Raymond James Maintains Outperform on Baxter Intl, Lowers Price Target to $85
Raymond James analyst Jayson Bedford maintains Baxter Intl (NYSE:BAX) with a Outperform and lowers the price target from $96 to $85.
Baxter International Q1 EPS $0.93 Beats $0.80 Estimate, Sales $3.71B Beat $3.68B Estimate
Baxter International (NYSE:BAX) reported quarterly earnings of $0.93 per share which beat the analyst consensus estimate of $0.80 by 16.25 percent. This is a 22.37 percent increase over earnings of $0.76 per share from
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Goldman Sachs Downgrades Baxter Intl to Sell, Lowers Price Target to $77
Goldman Sachs analyst Amit Hazan downgrades Baxter Intl (NYSE:BAX) from Neutral to Sell and lowers the price target from $88 to $77.
FDA Issues To Class I Recall To Baxter’s Spectrum Infusion Pump
In December 2021, Baxter International Inc (NYSE: BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps.
Baxter Receives Authorization From CVE Program To Be A CVE Numbering Authority
Baxter joins government sponsored Common Vulnerabilities and Exposures (CVE®) program as a CVE Numbering Authority
Program identifies, defines and catalogs publicly disclosed cybersecurity vulnerabilities to help
Analyst Ratings For Baxter Intl
Over the past 3 months, 6 analysts have published their opinion on Baxter Intl (NYSE:BAX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.